Alnylam Pharmaceuticals, Inc. (ALNY)
219.72
-11.46
(-4.96%)
USD |
NASDAQ |
Oct 02, 16:00
220.00
+0.28
(+0.13%)
After-Hours: 20:00
Alnylam Pharmaceuticals Market Cap : 29.38B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 29.38B |
| October 01, 2026 | 30.92B |
| September 30, 2026 | 33.00B |
| September 29, 2026 | 33.98B |
| September 28, 2026 | 34.15B |
| September 25, 2026 | 34.23B |
| September 24, 2026 | 33.38B |
| September 23, 2026 | 32.97B |
| September 22, 2026 | 33.65B |
| September 21, 2026 | 32.67B |
| September 18, 2026 | 32.04B |
| September 17, 2026 | 32.83B |
| September 16, 2026 | 32.01B |
| September 15, 2026 | 31.86B |
| September 14, 2026 | 33.43B |
| September 11, 2026 | 33.26B |
| September 10, 2026 | 33.10B |
| September 09, 2026 | 34.50B |
| September 08, 2026 | 34.78B |
| September 04, 2026 | 35.59B |
| September 03, 2026 | 35.37B |
| September 02, 2026 | 35.76B |
| September 01, 2026 | 32.91B |
| August 31, 2026 | 32.19B |
| August 28, 2026 | 31.71B |
| Date | Value |
|---|---|
| August 27, 2026 | 31.64B |
| August 26, 2026 | 31.96B |
| August 25, 2026 | 32.11B |
| August 24, 2026 | 31.56B |
| August 21, 2026 | 31.59B |
| August 20, 2026 | 30.67B |
| August 19, 2026 | 32.45B |
| August 18, 2026 | 30.57B |
| August 17, 2026 | 30.04B |
| August 14, 2026 | 30.58B |
| August 13, 2026 | 30.37B |
| August 12, 2026 | 29.95B |
| August 11, 2026 | 29.58B |
| August 10, 2026 | 29.02B |
| August 07, 2026 | 29.31B |
| August 06, 2026 | 28.90B |
| August 05, 2026 | 30.59B |
| August 04, 2026 | 29.29B |
| August 03, 2026 | 29.47B |
| July 31, 2026 | 27.49B |
| July 30, 2026 | 27.48B |
| July 29, 2026 | 38.33B |
| July 28, 2026 | 38.57B |
| July 27, 2026 | 37.23B |
| July 24, 2026 | 36.27B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Ionis Pharmaceuticals, Inc. | 7.212B |
| BridgeBio Pharma, Inc. | 13.13B |
| Vertex Pharmaceuticals, Inc. | 127.87B |
| Regeneron Pharmaceuticals, Inc. | 76.02B |
| Pfizer Inc. | 158.43B |
Market Cap Related Metrics
| PE Ratio | 37.10 |
| PS Ratio | 6.290 |
| Price to Book Value | 21.70 |
| Price to Free Cash Flow | 38.06 |
| Price | 219.72 |
| Earnings Yield | 2.70% |
| Operating PE Ratio | 30.23 |
| Normalized PE Ratio | 38.17 |